Sulfanilamide Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Sulfanilamide Price Trend, Index and Forecast
Track the latest insights on sulfanilamide price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Sulfanilamide Prices Outlook Q3 2025
- USA: USD 31244/MT
- China: USD 20886/MT
- Germany: USD 33060/MT
- South Korea: USD 36563/MT
- Brazil: USD 33255/MT
Sulfanilamide Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the sulfanilamide prices in the USA reached 31244 USD/MT in September. This price reflected an increase compared to the previous quarter. The uptick was mainly driven by rising demand in the pharmaceutical and agrochemical sectors, where sulfanilamide is used as a precursor in the production of antibiotics and pesticides. Prices were also increased due to supply-side factors, including higher raw material costs and increased production expenses due to inflationary pressures on labor and energy costs.
During the third quarter of 2025, the sulfanilamide prices in China reached 20886 USD/MT in September. The increase from Q2 prices was attributed to a tightening supply of sulfanilamide in the domestic market. Raw material shortages, exacerbated by disruptions in the global supply chain, led to higher production costs. Additionally, China’s domestic demand for sulfanilamide in the pharmaceutical industry increased.
During the third quarter of 2025, the sulfanilamide prices in Germany reached 33060 USD/MT in September. Prices fell due to a slowdown in pharmaceutical production as several large-scale contracts were delayed. Demand from the agrochemical sector remained steady, but a reduction in production volumes for other industries, including specialty chemicals, created an excess of sulfanilamide in the market, putting downward pressure on prices. The ongoing challenges in energy costs also had a mixed effect on manufacturing costs, with some companies adjusting production methods to maintain profitability without raising prices.
During the third quarter of 2025, the sulfanilamide prices in South Korea reached 36563 USD/MT in September. The decline was mainly due to a shift in demand dynamics within the domestic market. South Korean manufacturers faced a significant drop in orders from key export markets, primarily due to increasing competition from low-cost suppliers in Southeast Asia. Furthermore, raw material costs remained relatively stable, and there was little pressure from domestic production costs.
During the third quarter of 2025, the sulfanilamide prices in Brazil reached 33255 USD/MT in September. A key driver of price increase was the rising demand for sulfanilamide in the Brazilian pharmaceutical market, which is experiencing growth due to the country’s expanding healthcare sector. The domestic production of sulfanilamide was impacted by logistical challenges, including port congestion and transportation delays, which raised overall shipping costs.
Sulfanilamide Prices Outlook Q2 2025
- USA: USD 30780/MT
- China: USD 20435/MT
- Germany: USD 33460/MT
- South Korea: USD 37500/MT
- Brazil: USD 32660/MT
During the second quarter of 2025, sulfanilamide prices in the USA reached 30780 USD/MT in June. In the USA, sulfanilamide prices stayed steady, supported by consistent pharmaceutical demand and adequate domestic availability. Imports complemented supply chains, though stable raw material costs limited any strong upward momentum. Buyers adopted cautious procurement, aligning purchases with immediate needs. The absence of major disruptions in logistics or feedstock ensured smooth market flow. Overall, the US sulfanilamide market reflected stability, with balanced supply-demand dynamics and restrained market activity preventing significant price fluctuations during the quarter.
During the second quarter of 2025, sulfanilamide prices in China reached 20435 USD/MT in June. In China, sulfanilamide prices remained stable, supported by steady pharmaceutical sector consumption and strong domestic production capacity. Export activity was moderate, with regional demand taking precedence over international shipments. Raw material costs were steady, keeping production economics favorable and prices within a narrow range. Buyers followed cautious procurement patterns, meeting short-term requirements. With no major supply disruptions, the Chinese sulfanilamide market-maintained balance, marked by sufficient availability and consistent consumption, resulting in stable pricing throughout the quarter.
During the second quarter of 2025, the sulfanilamide prices in Germany reached 33460 USD/MT in June. In Germany, sulfanilamide prices reflected a stable to slightly soft tone, shaped by cautious buying trends from pharmaceutical and veterinary applications. Domestic supply was adequate, while imports ensured smooth availability across the market. Stable raw material values kept production costs in check, preventing significant fluctuations. Buyers avoided aggressive stockpiling, instead meeting immediate requirements. With balanced fundamentals and consistent but moderate demand, the German sulfanilamide market stayed steady, showing little volatility during the quarter while maintaining predictable trading patterns.
During the second quarter of 2025, the sulfanilamide prices in South Korea reached 37500 USD/MT in June. In South Korea, sulfanilamide prices remained stable, driven by steady demand from pharmaceutical intermediates and controlled supply conditions. Domestic producers maintained balanced operating rates, while imports supplemented availability when needed. Raw material costs stayed firm, supporting manageable production economics without causing major price swings. Buyers adopted conservative procurement strategies, aligning purchases with short-term needs. With no significant disruptions in supply chains or demand surges, the South Korean sulfanilamide market reflected steady fundamentals, ensuring stable pricing throughout the quarter.
During the second quarter of 2025, the sulfanilamide prices in Brazil reached 32660 USD/MT in June. In Brazil, sulfanilamide prices remained relatively stable, influenced by steady pharmaceutical sector demand and reliance on imports to meet domestic requirements. International market trends played a key role, though balanced global supply helped avoid sharp fluctuations. Buyers were cautious, focusing on short-term procurement and avoiding large-scale inventory buildup. Stable raw material values supported predictable pricing, while logistics remained smooth. Overall, the Brazilian sulfanilamide market displayed steady fundamentals, with adequate supply and moderate demand keeping prices within a stable range.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing sulfanilamide prices.
Europe Sulfanilamide Price Trend
Q3 2025:
During the third quarter of 2025, the sulfanilamide price index in Europe showed moderate fluctuations. Prices in key market like Germany experienced slight downward pressure due to a decrease in industrial demand, particularly from the agrochemical sector. Supply constraints from global markets, combined with high energy prices, caused production costs to rise. However, stable demand in the pharmaceutical sector helped mitigate larger price declines, leading to a relatively less bearish market.
Q2 2025:
As per the sulfanilamide price index, European sulfanilamide prices remained stable with a slightly soft tone due to cautious demand from pharmaceutical and veterinary applications. Producers maintained balanced operating rates to avoid inventory overhangs, while steady raw material costs kept production economics in check. Import flows were sufficient, ensuring smooth availability across the region. Buyers remained selective in procurement, focusing on immediate requirements rather than bulk purchases. Overall, the European sulfanilamide market reflected steady fundamentals, characterized by balanced supply and restrained demand activity.
This analysis can be extended to include detailed sulfanilamide price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Sulfanilamide Price Trend
Q3 2025:
In North America, the sulfanilamide price index for Q3 2025 saw steady growth, particularly in the USA. The main drivers of this increase were rising demand from both the pharmaceutical and agrochemical industries. Logistics challenges, including higher shipping costs and port congestion, further escalated prices. The strong USD also contributed to higher import costs for certain raw materials. While domestic production remained stable, external factors such as global supply chain issues, including delays in raw material shipments, helped push prices higher in Q3.
Q2 2025:
In North America, sulfanilamide prices stayed relatively stable, shaped by consistent demand from pharmaceutical manufacturing and controlled supply conditions. Domestic production was sufficient to meet market requirements, while imports supplemented availability without major disruptions. Buyers were cautious in procurement, with no rush toward stockpiling given predictable cost structures. Raw material stability ensured smooth production flows, keeping the market from sharp fluctuations. Overall, sulfanilamide prices in North America displayed steady fundamentals, supported by adequate supply and moderate but consistent consumption.
Specific data on sulfanilamide prices within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Sulfanilamide Price Trend
Q3 2025:
As per the sulfanilamide price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the sulfanilamide trends and sulfanilamide price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on sulfanilamide prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Sulfanilamide Price Trend
Q3 2025:
In the Asia Pacific, sulfanilamide prices increased moderately, especially in China, due to supply-side constraints and increasing domestic demand. Production disruptions in key manufacturing hubs, coupled with increasing labor and energy costs, led to price hikes in several countries. Additionally, export demand for sulfanilamide from Southeast Asian countries contributed to the price rise. Despite these increases, demand for sulfanilamide in other markets remained stable, keeping the regional market somewhat balanced. The continued expansion of the pharmaceutical sector in India and China further fueled demand in the region.
Q2 2025:
In the Asia-Pacific region, sulfanilamide prices demonstrated stability supported by consistent demand from pharmaceutical intermediates. China and India, being major producers, kept supply chains well-balanced, though competitive pricing restrained significant upward trends. Feedstock costs remained steady, ensuring manageable production economics. Export opportunities were moderate, with regional consumption acting as the key driver. End-use industries adopted cautious procurement strategies, aligning purchases with near-term needs. Overall, APAC’s sulfanilamide market reflected balanced fundamentals, characterized by stable costs, steady demand, and well-maintained supply.
This analysis can be further extended to include detailed sulfanilamide prices for a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Sulfanilamide Price Trend
Q3 2025:
Latin America showed a mixed pricing trend for sulfanilamide during Q3 2025. Brazil, as a key market, saw a slight price increase due to rising pharmaceutical demand. However, other countries in the region, faced price stagnation due to subdued market growth and difficulties in accessing raw materials. Logistics and supply chain inefficiencies in some South American countries continued to put pressure on pricing, particularly in more remote regions. Brazil's strong pharmaceutical market offset regional price challenges, contributing to an overall moderate upward movement in the region.
Q2 2025:
In Latin America, sulfanilamide prices reflected stability with a slight downward bias due to subdued demand from the pharmaceutical and veterinary drug sectors. Import dependency kept the market closely tied to global trade flows, while steady raw material costs prevented major volatility. Buyers maintained conservative purchasing strategies, focusing on immediate needs rather than long-term stocking. Overall, balanced supply conditions, adequate inventories, and cautious market activity contributed to a relatively calm pricing environment, with little room for upward momentum.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Sulfanilamide Price Trend, Market Analysis, and News
IMARC's latest publication, “Sulfanilamide Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the sulfanilamide market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of sulfanilamide at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed sulfanilamide prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting sulfanilamide pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Sulfanilamide Industry Analysis
The global sulfanilamide market size reached USD 41.18 Million in 2025. By 2034, IMARC Group expects the market to reach USD 57.55 Million, at a projected CAGR of 3.79% during 2026-2034. The market is primarily driven by the rising demand in the pharmaceutical and agrochemical sectors and the development of new applications and advancements in pharmaceutical formulations.
Latest developments in the sulfanilamide industry:
- July 2025: A recent study focused on synthesizing sulfanilamide derivatives to evaluate their anti-cancer potential. Ten derivatives were synthesized using a reflux condensation method. Among them, compound 5d exhibited the highest antioxidant activity and significant inhibition against carbonic anhydrase II (CA-II).
Product Description
Sulfanilamide is a synthetic antimicrobial agent that falls under the sulfonamide class of antibiotics. These drugs were the first to be widely utilized as successful chemotherapeutics to treat bacterial infections. Its chemical structure consists of a sulfonamide group (SO₂NH₂) linked to an aniline group (an aromatic amine). Many additional sulfonamide medications, each with a different level of effectiveness and specificity for distinct bacterial illnesses, are based on this basic structure.
Sulfanilamide's mechanism of action involves the inhibition of the bacterial enzyme dihydropteroate synthase, which is crucial in the synthesis of folic acid. Bacteria need folic acid to produce essential nucleic acids (DNA and RNA) and other metabolites. By blocking this pathway, sulfanilamide prevents bacterial growth and multiplication, exerting a bacteriostatic effect.
Sulfanilamide was initially used to treat streptococcal infections, and its success led to the development of many other sulfonamide antibiotics that are used for treating UTIs, some types of meningitis, and certain forms of pneumonia, particularly in patients allergic to penicillin. Additionally, it is used in combination with other drugs to treat specific parasitic infections.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Sulfanilamide |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of sulfanilamide pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting sulfanilamide price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the sulfanilamide industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.